Xijie Yang

Artiklar

Article: CANCER LETTERS. 2022;532:215594
Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer.
Yang X; Zeng Z; Jie X; Wang Y; Han J; Zheng Z; Li J; Liu H; Dong X; Wu G; Xu S
Article: CELL DEATH & DISEASE. 2022;13(2):110
REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis.
Chen Y; Jie X; Xing B; Wu Z; Yang X; Rao X; Xu Y; Zhou D; Dong X; Zhang T; Yang K; Li Z; Wu G
Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2022;10(2):e003716
Targeting KDM4C enhances CD8+ T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer.
Jie X; Chen Y; Zhao Y; Yang X; Xu Y; Wang J; Meng R; Zhang S; Dong X; Zhang T; Yang K; Xu S; Wu G
Article: CELL DEATH DISCOVERY. 2022;8(1):36
Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors.
Xu Y; Wang J; Wang X; Zhou X; Tang J; Jie X; Yang X; Rao X; Xu Y; Xing B; Li Z; Wu G
Article: CELL DEATH AND DIFFERENTIATION. 2021;28(2):671-684
UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance.
Huang Y; Yang X; Lu Y; Zhao Y; Meng R; Zhang S; Dong X; Xu S; Wu G
Article: THERANOSTICS. 2020;10(24):11144-11158
Cyclin K interacts with β-catenin to induce Cyclin D1 expression and facilitates tumorigenesis and radioresistance in lung cancer.
Yao G; Tang J; Yang X; Zhao Y; Zhou R; Meng R; Zhang S; Dong X; Zhang T; Yang K; Wu G; Xu S